Back to User profile » Dr Wenjuan Yan
Papers published by Dr Wenjuan Yan:
Ceftazidime-Avibactam Combination Therapy versus Monotherapy for the Treatment Carbapenem-Resistant Gram-Negative Bacterial Infections: A Retrospective Observational Study
Li K, Li D, Dong H, Ren D, Gong D, Wang S, Li Y, Wu Y, Yang J, Yan W, Li Y
Infection and Drug Resistance 2024, 17:1281-1289
Published Date: 29 March 2024
Microbiological Analysis and Mortality Risk Factors in Patients with Polymicrobial Bloodstream Infections
Xu J, Yuan Y, Wang B, Zhang Q, Wang J, Wang S, Li Y, Yan W
Infection and Drug Resistance 2023, 16:3917-3927
Published Date: 20 June 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China
Zhang Q, Yan W, Zhu Y, Jing N, Wang S, Yuan Y, Ma B, Xu J, Chu Y, Zhang J, Ma Q, Wang B, Xu W, Zhu L, Sun Y, Shi C, Fang J, Li Y, Liu S
Infection and Drug Resistance 2023, 16:1171-1181
Published Date: 27 February 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Sequence Type 11 Due to a Mutation in Plasmid-Borne blakpc-2 to blakpc-33, in Henan, China
Li D, Li K, Dong H, Ren D, Gong D, Jiang F, Shi C, Li J, Zhang Q, Yan W, Li Y
Infection and Drug Resistance 2021, 14:1725-1731
Published Date: 10 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes
Yuan Y, Wang J, Yao Z, Ma B, Li Y, Yan W, Wang S, Ma Q, Zhang J, Xu J, Li L, Wang Y, Fan E
Infection and Drug Resistance 2020, 13:207-215
Published Date: 22 January 2020